Wiessing, Lucas, Banka-Cullen, Sonam Prakashini, Barbaglia, M. Gabriela, Belackova, Vendula, Belbaisi, Saed AS, Blanken, Peter, Carrieri, Patrizia, Comiskey, Catherine
ORCID: https://orcid.org/0000-0003-3528-777X, Dacosta-Sánchez, Daniel, Dom, Geert, Fabricius, Venus, Faria, Hugo, Ignjatova, Liljana, Inić, Nemanja, Jacobsen, Britta, Javakhishvili, Jana D, Kamendy, Zuzana, Kapitány-Fövény, Máté, Kiss, Anna, Kyprianou, Evi, Marchand, Kirsten, Millar, Tim, Mravcik, Viktor, Mustafa, Naser JY, Nordt, Carlos, Partanen, Markus, Uffe Pedersen, Mads, Putkonen, Hanna, Razmadze, Mariam, Roux, Perrine, Schulte, Bernd, Seabra, Paulo, Sordo, Luis, Strada, Lisa, Subata, Emilis, Thoma, Esmeralda, Torrens, Marta, Walley, Alexander Y and Yiasemi, Ioanna
(2023)
Opioid agonist maintenance treatment outcomes—the OPTIMUS international consensus towards evidence-based and patient-centred care, an interim report.
International Journal of Mental Health and Addiction,
pp. 2004-2020.
https://doi.org/10.1007/s11469-023-01213-9.
External website: https://link.springer.com/article/10.1007/s11469-0...
Non-medical opioid use is a major public health concern causing high mortality. While opioid agonist maintenance treatment (OMT) is a key life-saving intervention, there is (a) no international consensus on opioid treatment outcomes and (b) few opioid treatment outcome studies include key (public) health outcomes, such as overdose or HIV/hepatitis C. We report the rationale and study protocol for, and preliminary results of, an ongoing international OMT outcomes consensus study that aims to address this double gap (n = 110 collaborating experts from 32 countries, plus a n = 477 Delphi evaluation panel from 26 of those countries: 58% male–41% female; 47% OMT patients–53% OMT professionals). We present a first draft of a patient interview guide (including a ‘clinical form’) to monitor OMT outcomes in six domains. The form appears to be well accepted and feasible in early testing. Through this, we aim to enhance the quality of and access to OMT, and improve the survival, health and quality of life of people who use opioids, while promoting non-stigmatising patient-physician relationships.
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
B Substances > Opioids (opiates) > Opioid product > Methadone
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
HJ Treatment or recovery method > Treatment outcome
J Health care, prevention, harm reduction and treatment > Patient / client care management
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Patient / client attitude toward treatment (experience)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Provider / worker / staff attitude toward treatment
VA Geographic area > International
Repository Staff Only: item control page